Calreticulin: Raising awareness of apoptosis

Apoptosis

Volumn 12, Issue 4, 2007, Pages 631-634

  Waterhouse, Nigel J ^a,b   Pinkoski, Michael J ^c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

Apoptosis; Calreticulin; Chemotherapy; Immunogenicity; Phagocytosis

Indexed keywords

CALCIUM; CALRETICULIN;

APOPTOSIS; ARTICLE; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CELL STRESS; CELLULAR STRESS RESPONSE; CYTOTOXICITY; DENDRITIC CELL; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOREGULATION; IMMUNOSTIMULATION; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FOLDING; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CALRETICULIN; IMMUNE SYSTEM; NEOPLASMS; PHAGOCYTOSIS;

EID: 33947106852     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0057-9     Document Type: Article

References (25)

1. Sauter B, Albert ML, Francisco L et al (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423-434
2. Casares N, Pequignot MO, Tesniere A et al (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202:1691-1701
3. Pinkoski MJ, Waterhouse NJ, Green DR (2006) Mitochondria, apoptosis and autoimmunity. Curr Dir Autoimmun 9:55-73
4. Obeid M, Tesniere A, Ghiringhelli F et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54-61
5. Porcellini S, Traggiai F, Schenk U et al (2006) Regulation of peripheral T cell activation by calreticulin. J Exp Med 203:461-471
6. Dupuis M, Schaerer E, Krause KH, Tschopp J (1993) The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes. J Exp Med 177:1-7
7. 2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules. Biochemistry 37:10386-10394
8. Sipione S, Ewen C, Shostak I, Michalak M, Bleackley RC (2005) Impaired cytolytic activity in calreticulin-deficient CTLs. J Immunol 174:3212-3219
9. Ogden CA, Elkon KB (2006) Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr Dir Autoimmun 9:120-142
10. Gardai SJ, Bratton DL, Ogden CA, Henson PM (2006) Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 79:896-903
11. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89
12. Zeng Y, Chen X, Larmonier N et al (2006) Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination. Int J Can 119:2624-2631
13. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12:1539-1546
14. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-313
15. Gregory CD, Brown SB (2005) Apoptosis: eating sensibly. Nat Cell Biol 7:1161-1163
16. Henson PM, Bratton DL, Fadok VA (2001) The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2:627-633
17. Boatright KM, Salvesen GS (2003) Mechanisms of caspase activation. Curr Opin Cell Biol 15:725-731
18. Wolf BB, Schuler M, Echeverri F, Green DR (1999) Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 274:30651-30656
19. Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276:7320-7326
20. Ekert PG, Jabbour AM, Manoharan A et al (2006) Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood 108:1461-1468
21. Walczak H, Krammer PH (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256:58-66
22. Waterhouse NJ, Sutton VR, Sedelies KA et al (2006) Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis. J Cell Biol 173:133-144
23. Rauch F, Prud'homme J, Arabian A, Dedhar S, St-Arnaud R (2000) Heart, brain, and body wall defects in mice lacking calreticulin. Exp Cell Res 256:105-111
24. Kinchen JM, Cabello J, Klingele D et al (2005) Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans. Nature 434:93-99
25. Kim R, Emi M, Tanabe K (2005) Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses. Cancer Biol Ther 4:924-933